Henrik Gronfeldt-Sorensen - 11 Oct 2021 Form 4/A - Amendment Insider Report for Enochian Biosciences Inc (RENB)

Role
Director
Signature
/s/ Henrik Gronfeldt-Sorensen
Issuer symbol
RENB
Transactions as of
11 Oct 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
04 Jan 2022, 17:08:51 UTC
Date Of Original Report
22 Dec 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Option to purchase shares of common stock Award $0 +10,519 $0.000000 10,519 11 Oct 2021 Common stock 10,519 $7.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is amending the Form 4 originally filed to report that the form of ownership is direct and not indirect.